Patent ID: 11911465
Assignee: PDS BIOTECHNOLOGY CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A

Claim 11:
12. A method of treating a disease in a mammal, said method comprising the step of administering an effective amount of a vaccine composition to the mammal, wherein the vaccine composition comprises a lipid and at least one antigen, wherein the lipid consists of a cationic lipid and wherein the cationic lipid consists of R-DOTAP, and wherein the antigen is a multi-epitope viral antigen and wherein the vaccine composition is administered to the mammal in an amount sufficient to effect antigen cross presentation to induce a humoral and a CD8+ T cell response in the mammal and wherein the CD 8+ T-cell response is enhanced by at least 2-fold over that elicited by the viral antigen alone.